Healthcare news and intelligence for Southern Africa
Daily reporting for the pharmaceutical, medical scheme and hospital sectors, published by Health Matters since 1994.
8 October 2026
Cancer in South Africa is rising, with deaths forecast to nearly double by 2050. Learn what ageing, smoking and urbanisation mean for care.
Latest
8 October 2026
8 October 2026
6 October 2026
6 October 2026
5 October 2026
More news
6 August 2026
5 August 2026
Lenacapavir production moves closer in SA as three local pharmaceutical manufacturers are shortlisted to produce the HIV-prevention injection.
5 August 2026
3 August 2026
Sixty60 pharmacy delivery could reset South Africa's chemist market, letting Shoprite's Medirite challenge Clicks and Dis-Chem.
3 August 2026
Older adults with HIV will nearly double by 2040. South Africa faces one of the sharpest rises, straining health systems.
29 July 2026
Rosebank Health Village, a R100 million Growthpoint and Epione development, brings specialists, diagnostics and day surgery together.
28 July 2026
Global HIV funding cuts pushed financing to a 20-year low in 2025, threatening prevention, research and the goal of ending AIDS by 2030.
27 July 2026
Aspen HIV prevention pill licensing deal positions the SA manufacturer to supply lower-cost monthly PrEP across key African markets.
27 July 2026
The Dis-Chem leadership succession ends as co-founder Ivan Saltzman leaves the board after 48 years, ending the family's representation.
24 July 2026
The Extensior launch in South Africa offers 15% lower semaglutide prices, but Discovery Health says scheme coverage is unlikely to expand.
23 July 2026
Generic drug tariffs could raise US medicine costs, disrupt global supply chains and pressure manufacturers to move production to America.
23 July 2026
Medicine safety is in focus as the iDexis court case raises questions about compounding, regulation and patient monitoring.
The archive
Browse every Health Matters article by month.